TRAIL receptor-targeted therapy

Author： Buchsbaum Donald J   Zhou Tong   LoBuglio Albert F  

Publisher： Future Medicine

ISSN： 1479-6694

Source： Future Oncology, Vol.2, Iss.4, 2006-08, pp. : 493-508

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Epidermal Growth Factor Receptor-Targeted Therapy for Pancreatic Cancer

By Papageorgio Chris   Perry Michael  

Cancer Investigation, Vol. 25, Iss. 7, 2007-10 ,pp. : 647-657

Informa Healthcare

Access to resources Recommend Favorite

Can we predict the response to epidermal growth factor receptor targeted therapy?

By Manegold Philipp  

Targeted Oncology, Vol. 3, Iss. 2, 2008-04 ,pp. : 87-99

Springer Publishing Company

Access to resources Recommend Favorite

Increased ERK activation and cellular drug accumulation in the enhanced cytotoxicity of folate receptor-targeted liposomal carboplatin

By Chaudhury Anumita   Tan Bee Jee   Das Surajit   Chiu Gigi N.C.  

International Journal of Oncology, Vol. 40, Iss. 3, 2012-03 ,pp. : 703-710

Spandidos Publications

Access to resources Recommend Favorite

TRAIL combinations: The new ‘trail’ for cancer therapy (Review)

By      

Oncology Letters, Vol. 7, Iss. 5, 2014-01 ,pp. : 1327-1332

Spandidos Publications

Access to resources Recommend Favorite

Effect of integrin receptortargeted liposomal paclitaxel for hepatocellular carcinoma targeting and therapy

By        

Oncology Letters, Vol. 10, Iss. 1, 2015-01 ,pp. : 77-84

Spandidos Publications

Access to resources Recommend Favorite